Search

Author/Creator Komoly, Samuel

1. Amifampridine phosphate (Firdapse®) is effective and safe in a phase 3 clinical trial in LEMS. Issue 5 (3rd March 2016)

Authors:
Oh, Shin J; Shcherbakova, Natalya; Kostera‐Pruszczyk, Anna; Alsharabati, Mohammad; Dimachkie, Mazen; Blanco, Jose Munoz; Brannagan, Thomas; Lavrnić, Dragana; Shieh, Perry B; Vial, Christophe; Meisel, Andreas; Komoly, Samuel; Schoser, Benedikt; Sivakumar, Kumaraswamy; So, Yuen
Journal:
Muscle & nerve
Issue:
Volume 53:Issue 5(2016)
Page Start:
717
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quantitative assessment of brain iron by R2* relaxometry in patients with cervical dystonia. Issue 10 (30th July 2015)

Authors:
Aschermann, Zsuzsanna; Perlaki, Gabor; Orsi, Gergely; Nagy, Szilvia Anett; Horvath, Andrea; Bone, Beata; Bihari, Katalin; Acs, Peter; Janszky, Jozsef; Komoly, Samuel; Bogner, Peter
Journal:
Movement disorders
Issue:
Volume 30:Issue 10(2015)
Page Start:
1422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS). (22nd April 2013)

Authors:
Preiningerova, Jana Lizrova; Baumhackl, Ulf; Csepany, Tunde; Czaplinski, Adam; Deisenhammer, Florian; Derfuss, Tobias; Fabjan, Tanja H.; Fazekas, Franz; Fuchs, Siegrid; Havrdova, Eva; Ledinek, Alenka Horvath; Illes, Zsolt; Jazbec, Sasa Sega; Klimova, Eleonora; Komoly, Samuel; Kurca, Egon; Linneba...
Journal:
CNS neuroscience & therapeutics
Issue:
Volume 19:Number 5(2013)
Page Start:
302
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗